William H Beierwaltes

Title: William H Beierwaltes: Innovator in Radiopharmaceuticals

Introduction

William H Beierwaltes is a notable inventor based in Ann Arbor, MI (US). He has made significant contributions to the field of nuclear medicine, particularly through his innovative work in radiopharmaceuticals. With a total of 2 patents, Beierwaltes has developed groundbreaking technologies that enhance medical imaging and treatment.

Latest Patents

One of his latest patents is titled "Imaging agent and method of use." This patent describes a new radiopharmaceutical composition that includes a radioiodinated meta-iodobenzylguanidine. The composition serves as an imaging agent for the heart, adrenal medulla, and tumors of the adrenal medulla. It also has potential applications in the treatment of tumors in the adrenal medulla. Another significant patent is focused on "Monoclonal antibodies specific for the unbound beta subunit of human chorionic gonadotropin." This patent involves hybrid-myeloma cells that produce a monoclonal antibody specific to the beta subunit and outlines methods for its use.

Career Highlights

Throughout his career, Beierwaltes has worked with prestigious institutions, including the University of Michigan. His work has been instrumental in advancing the field of nuclear medicine and improving diagnostic techniques.

Collaborations

Beierwaltes has collaborated with notable colleagues such as Mohammad B Khazaeli and Barry G England. These partnerships have contributed to the success of his research and innovations.

Conclusion

William H Beierwaltes is a distinguished inventor whose work in radiopharmaceuticals has made a lasting impact on nuclear medicine. His innovative patents and collaborations highlight his commitment to advancing medical technology.